Print Page   |   Sign In   |   Join
SlitLamp E-News
Blog Home All Blogs
SlitLamp provides illuminating e-news for Colorado ophthalmologists. It keeps you in the know on the evolving Colorado health care scene by detailing the latest legislative and regulatory happenings. It also spotlights the information and resources you need for your practice.

 

Search all posts for:   

 

Top tags: advocacy  health plans  practice management  2014 legislative session  Avastin  MACRA  AAO  Coffman  compounding  CSEPS Connect  FDA  health advisory alert  HIPAA  IPAB  legislator  Medicaid  Medicare  member meeting  mergers  MIPs  pay issues  payer issues  payment reform  PDMP  QPP  reimbursement  repackaged drugs  US Congress 

Health advisory alert: Request for cases of adverse reactions to ocular Avastin injections

Posted By Chet Seward, Saturday, December 24, 2016

The following is an important health advisory alert from the Colorado Department of Public Health and Environment (CDPHE).

  • CDPHE is investigating a cluster of adverse outcomes following intravitreal injections with Avastin to treat macular degeneration. The investigation is ongoing.
  • The patients experienced inflammatory reactions, including clouded vision, decreased vision and floaters within a few days after intravitreal injection with Avastin. All patients recovered following treatment with topical steroids.
  • CDPHE requests any cases of inflammatory reactions following ocular Avastin use be reported to the Communicable Disease Branch by contacting Devra Barter at 303-692-2706 or devra.barter@state.co.us. You also may contact Devra Barter for more information.

Tags:  Avastin  health advisory alert 

Share |
PermalinkComments (0)
 

CSEPS presses for FDA changes on repackaged and compounded drug products

Posted By Chet Seward, Tuesday, July 15, 2014
Share |
PermalinkComments (0)